SCHEMBL4897972

SCHEMBL4897972

C[C@H](Nc1c(NCc2ccc3[nH]nnc3c2)c(=O)c1=O)c1cccc(O)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPKAPK2 P49137 8/20 0.47
HDAC1 Q13547 3/20 0.38
OPRK1 P41145 1/20 0.36
CDK1 P06493 2/20 0.36
CCNB2 O95067 1/20 0.36
CCNB1 P14635 1/20 0.36
CCNB3 Q8WWL7 1/20 0.36
ROCK1 Q13464 5/20 0.35
AURKB Q96GD4 4/20 0.35
MAPK1 P28482 3/20 0.35
ROCK2 O75116 3/20 0.35
GSK3B P49841 3/20 0.35
CLK4 Q9HAZ1 3/20 0.35
CHEK2 O96017 2/20 0.35
PRKX P51817 2/20 0.35
CDC42BPA Q5VT25 2/20 0.35
BRSK1 Q8TDC3 2/20 0.35
STK17A Q9UEE5 2/20 0.35
PRKG1 Q13976 2/20 0.35
PLK4 O00444 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4900221 1.00 MAPKAPK2 (0.47) MAPKAPK2HDAC1OPRK1CDK1CCNB2
SCHEMBL4598143 0.88 SRC (0.41) MAPKAPK2OPRK1CDK1CCNB2CCNB1
SCHEMBL4907742 0.84 MAPKAPK2 (0.47) MAPKAPK2HDAC1OPRK1CDK1CCNB2
SCHEMBL4900151 0.84 MAPKAPK2 (0.47) MAPKAPK2HDAC1OPRK1CDK1CCNB2
SCHEMBL4598150 0.74 PRKD3 (0.45) OPRK1CDK1CCNB2CCNB1CCNB3
SCHEMBL4898767 0.70 RPS6KB1 (0.40) CDK1CCNB2CCNB1CCNB3ROCK1
SCHEMBL1228354 0.68 MAPKAPK2 (0.60) MAPKAPK2ROCK1AURKBMAPK1ROCK2
SCHEMBL1229252 0.67 MAPKAPK2 (0.59) MAPKAPK2ROCK1AURKBMAPK1ROCK2
SCHEMBL1228404 0.67 MAPKAPK2 (0.61) MAPKAPK2CDK1ROCK1AURKBMAPK1
SCHEMBL4596962 0.67 MAPKAPK2 (0.61) MAPKAPK2ROCK1AURKBMAPK1ROCK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080234266-A1 Squaric Acid Derivatives II MERCK PATENT GESELLSCHAFT (DE) 2008-09-25 US claimed
US-20080234266-A1 Squaric Acid Derivatives II MERCK PATENT GESELLSCHAFT (DE) 2008-09-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080234266-A1 Squaric Acid Derivatives II CHEK2, CHEK1, SGK3 MAPKAPK2 346/4885HDAC1 1193/4885OPRK1 3286/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.